Latest News

One generates 9% net margins with nuclear-powered data center deals; the other pulls 25% margins from regulated utilities and renewables.

Nvidia stock popped following its latest quarterly report, setting it up for a solid September.

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M

Lululemon is currently in the midst of a difficult year.

It might be the right time to buy VPU instead of VOO.

Okta, CrowdStrike, Datadog, Cloudflare and Palo Alto Networks led Q2's most-upgraded stocks as AI-driven agentic traffic boosts cybersecurity demand, with analysts raising price targets and ratings.

What Happened? Shares of health and wellness products company Herbalife (NYSE:HLF) fell 13.2% in the afternoon session after the company announced that Chief...

What Happened? Shares of cybersecurity platform provider CrowdStrike (NASDAQ:CRWD) jumped 4.0% in the afternoon session after the company introduced its new ...

OpenAI just valued itself at $852 billion in a $7 billion employee share sale -- and a possible IPO could push that figure past $1 trillion.

If Edison International sparks a wildfire, it will have to pay for it.

Video footage and information about "Grand Theft Auto VI" is leaking ahead of the game's release. Should investors worry?

Metaplanet CEO Simon Gerovich says Bitcoin has bottomed and expects a stronger finish to 2026.

What Happened? Shares of government IT services provider Science Applications International Corporation (NASDAQ:SAIC) jumped 5.5% in the afternoon session af...

Rogers trimmed his direct holdings by 3% after the stock surged 695% over the past 12 months.

Vanguard's S&P 500 ETF is still a solid long-term investment.

Broadcom's revenue and profits are growing fast, but investors have mostly stayed away.

Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead.

All good things must come to an end -- it's just hard to know when that will be.

A renewed Middle East conflict knocked stocks lower Monday. Zoom out, though, and August was a winning month led by tech earnings.

Bitcoin investors could be in for more strong returns over the rest of the year.

George Santos gets Kalshi’s first lifetime ban and a $71,356 penalty over bets on his own State of the Union attendance.

AON (NYSE:AON) said it has entered a definitive agreement to acquire U.S. middle-market insurance broker USI in an all-cash transaction valued at approximately $17 billion, or $16.7 billion net of certain tax attributes. The company expects the deal to close in the fourth quarter of 2026, subject to

Take-Two Interactive Software Inc (NASDAQ:TTWO) shares are falling Monday, potentially facing selling pressure tied to a string of leaks surrounding "Grand Theft Auto VI" ahead of the game's Nov. 19 release.

Brent climbed after new U.S.-Iran strikes, pushing the 10-year yield to a 19-month high; Edison and PG&E collapsed on a wildfire bill.